• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌中ras基因突变的高发生率。

High incidence of ras gene mutation in intrahepatic cholangiocarcinoma.

作者信息

Tada M, Omata M, Ohto M

机构信息

First Department of Medicine, Chiba University School of Medicine, Japan.

出版信息

Cancer. 1992 Mar 1;69(5):1115-8. doi: 10.1002/cncr.2820690509.

DOI:10.1002/cncr.2820690509
PMID:1739910
Abstract

The DNA sequences around codons 12, 13, and 61 of the ras gene were analyzed by polymerase chain reaction and direct sequencing in 18 intrahepatic cholangiocarcinomas. The ras gene mutations were found in 9 of 18 (50%): 6 in K-ras codon 12, 1 in K-ras codon 13, 1 in K-ras codon 61, and 1 in N-ras codon 12. The incidence of mutations was higher in the hilar type of intrahepatic cholangiocarcinomas, especially when these tumors were large. The incidence and spectrum of the mutations were almost the same as those reported in colon cancers, possibly indicating similar etiologic agent(s) in the carcinogenesis of both cancers.

摘要

通过聚合酶链反应和直接测序法,对18例肝内胆管癌中ras基因第12、13和61密码子周围的DNA序列进行了分析。在18例中有9例(50%)发现了ras基因突变:K-ras第12密码子突变6例,K-ras第13密码子突变1例,K-ras第61密码子突变1例,N-ras第12密码子突变1例。肝门部肝内胆管癌的突变发生率更高,尤其是肿瘤体积较大时。这些突变的发生率和谱与结肠癌中报道的几乎相同,这可能表明两种癌症在致癌过程中有相似的病因。

相似文献

1
High incidence of ras gene mutation in intrahepatic cholangiocarcinoma.肝内胆管癌中ras基因突变的高发生率。
Cancer. 1992 Mar 1;69(5):1115-8. doi: 10.1002/cncr.2820690509.
2
[Detection of ras gene mutations of primary hepatic malignant tumors by polymerase chain reaction and direct sequencing method].[聚合酶链反应及直接测序法检测原发性肝脏恶性肿瘤的ras基因突变]
Nihon Shokakibyo Gakkai Zasshi. 1990 Mar;87(3):811-5.
3
The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.
J Med Assoc Thai. 1998 May;81(5):316-23.
4
Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing.通过聚合酶链反应和直接测序分析人类肝脏恶性肿瘤中的ras基因突变
Cancer Res. 1990 Feb 15;50(4):1121-4.
5
Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.日本和泰国肝内胆管细胞癌中p53肿瘤抑制基因和ras基因家族的突变
Mol Carcinog. 1993;8(4):312-8. doi: 10.1002/mc.2940080415.
6
[Detection of ras gene mutations of pancreatic tumors by polymerase chain reaction and direct sequencing method].
Nihon Shokakibyo Gakkai Zasshi. 1989 Nov;86(11):2566-71.
7
Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections.石蜡包埋组织切片中壶腹周围癌、胆囊癌和胆管癌的K-ras基因突变分析
J Formos Med Assoc. 1995 Dec;94(12):719-23.
8
K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.K-ras基因第12和13密码子突变与结直肠癌患者肿瘤细胞播散的不同模式相关。
Int J Oncol. 2004 Jun;24(6):1537-44.
9
Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
Gastroenterology. 1991 Jan;100(1):233-8. doi: 10.1016/0016-5085(91)90606-l.
10
Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.肝内胆管癌中微卫星不稳定性、K-ras基因突变及p53蛋白过表达的分析
Hepatogastroenterology. 2002 May-Jun;49(45):604-8.

引用本文的文献

1
An integrative study on the impact of highly differentially methylated genes on expression and cancer etiology.关于高度差异甲基化基因对表达及癌症病因影响的综合研究。
PLoS One. 2017 Feb 8;12(2):e0171694. doi: 10.1371/journal.pone.0171694. eCollection 2017.
2
A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.一种通过肝脏特异性Kras激活和Pten缺失诱导的肝内胆管癌新型小鼠模型。
Sci Rep. 2016 Apr 1;6:23899. doi: 10.1038/srep23899.
3
Perioperative Management of Hilar Cholangiocarcinoma.
肝门部胆管癌的围手术期管理
J Gastrointest Surg. 2015 Oct;19(10):1889-99. doi: 10.1007/s11605-015-2854-8. Epub 2015 May 29.
4
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.综合基因组特征揭示了散发性肝内胆管癌中FGFR和EGFR通路中新型的、具有治疗相关性的药物靶点。
PLoS Genet. 2014 Feb 13;10(2):e1004135. doi: 10.1371/journal.pgen.1004135. eCollection 2014 Feb.
5
Pathogenesis, diagnosis, and management of cholangiocarcinoma.胆管癌的发病机制、诊断和治疗。
Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15.
6
Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.PI3K/AKT信号通路的激活增加与胆管癌转移相关,PI3K/mTOR抑制是一种可能的治疗策略。
Tumour Biol. 2013 Dec;34(6):3637-48. doi: 10.1007/s13277-013-0945-2. Epub 2013 Jul 6.
7
Genetic profiling of intrahepatic cholangiocarcinoma.肝内胆管癌的基因谱分析。
Curr Opin Gastroenterol. 2012 May;28(3):266-72. doi: 10.1097/MOG.0b013e3283523c7e.
8
Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?肝癌和肝内胆管细胞癌的分子致癌学:更接近个体化医学了吗?
Cell Biosci. 2011 Jan 24;1(1):5. doi: 10.1186/2045-3701-1-5.
9
Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.胰腺癌和胆管癌化疗的近期进展与局限性
World J Clin Oncol. 2011 Mar 10;2(3):158-63. doi: 10.5306/wjco.v2.i3.158.
10
New insights on cholangiocarcinoma.胆管癌的新见解。
World J Gastrointest Oncol. 2010 Mar 15;2(3):136-45. doi: 10.4251/wjgo.v2.i3.136.